Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7410-57-3

Post Buying Request

7410-57-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7410-57-3 Usage

Properties

contains a cyclohexane-1,2-dione moiety and a phenyl group

Potential biological activities

antimicrobial, antioxidant, and antitumor properties
Use in organic synthesis as a reagent for the preparation of various organic compounds
Interest to researchers and scientists for potential pharmacological and medicinal applications

Check Digit Verification of cas no

The CAS Registry Mumber 7410-57-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,4,1 and 0 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 7410-57:
(6*7)+(5*4)+(4*1)+(3*0)+(2*5)+(1*7)=83
83 % 10 = 3
So 7410-57-3 is a valid CAS Registry Number.

7410-57-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name [[(E)-(2-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)-phenylmethyl]amino]thiourea

1.2 Other means of identification

Product number -
Other names 2,4-dihydroxybenzophenone thiosemicarbazone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7410-57-3 SDS

7410-57-3Downstream Products

7410-57-3Relevant articles and documents

Design and synthesis of new benzophenone derivatives with in vivo anti-inflammatory activity through dual inhibition of edema and neutrophil recruitment

Januario, Jaqueline P.,De Souza, Thiago B,Lavorato, Stefania N.,Maiolini, Tatiane C. S.,Domingos, Olívia S,Baldim, Jo?o L,Folquitto, Laís R. S.,Soares, Marisi G.,Chagas-Paula, Daniela A,Dias, Danielle F,Dos Santos, Marcelo H

, (2018/08/04)

A series of novel benzophenone derivatives containing a thiazole heterocyclic nucleus were designed by molecular hybridization. Molecular docking studies have demonstrated the inhibitory potential of the designed compounds against cyclooxygenase (COX) isoenzymes. These compounds were synthesized, characterized, and evaluated for their anti-inflammatory properties by the croton oil-induced ear edema assay to examine their effect on both prostaglandin (PG) production and neutrophils recruitment. The thiazole derivatives displayed a potent effect in terms of reducing ear edema. The analysis suggested that the presence of 4-phenyl-2-hydrazinothiazole and the absence of C40-OCH3 on the benzophenone derivative structure are strongly related to the inhibition of PG production. In addition, the derivatives 2e, 3a and 3c concomitantly inhibit PG production and neutrophil recruitment, which may be a mechanism of action better than of common NSAIDs due to their inability to inhibit the neutrophil recruitment. Thus, these compounds can be considered as potential lead compounds toward the development of new anti-inflammatory drugs with an innovating mechanism of action.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7410-57-3